Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function
Madhusudhanan Sukumar,Jie Liu,Yun Ji,Murugan Subramanian,Joseph G. Crompton,Zhiya Yu,Rahul Roychoudhuri,Douglas C. Palmer,Pawel Muranski,Edward D. Karoly,Robert P. Mohney,Christopher A. Klebanoff,Ashish Lal,Toren Finkel,Nicholas P. Restifo,Luca Gattinoni +15 more
Reads0
Chats0
TLDR
It is indicated that augmenting glycolytic flux drives CD8+ T cells toward a terminally differentiated state, while its inhibition preserves the formation of long-lived memory CD8+, and the efficacy of T cell-based therapies against chronic infectious diseases and cancer.Abstract:
Naive CD8+ T cells rely upon oxidation of fatty acids as a primary source of energy. After antigen encounter, T cells shift to a glycolytic metabolism to sustain effector function. It is unclear, however, whether changes in glucose metabolism ultimately influence the ability of activated T cells to become long-lived memory cells. We used a fluorescent glucose analog, 2-NBDG, to quantify glucose uptake in activated CD8+ T cells. We found that cells exhibiting limited glucose incorporation had a molecular profile characteristic of memory precursor cells and an increased capacity to enter the memory pool compared with cells taking up high amounts of glucose. Accordingly, enforcing glycolytic metabolism by overexpressing the glycolytic enzyme phosphoglycerate mutase-1 severely impaired the ability of CD8+ T cells to form long-term memory. Conversely, activation of CD8+ T cells in the presence of an inhibitor of glycolysis, 2-deoxyglucose, enhanced the generation of memory cells and antitumor functionality. Our data indicate that augmenting glycolytic flux drives CD8+ T cells toward a terminally differentiated state, while its inhibition preserves the formation of long-lived memory CD8+ T cells. These results have important implications for improving the efficacy of T cell–based therapies against chronic infectious diseases and cancer.read more
Citations
More filters
Journal ArticleDOI
Combined angiogenesis and PD-1 inhibition for immunomodulatory TNBC: concept exploration and biomarker analysis in the FUTURE-C-Plus trial
Song-Yang Wu,Ying Xu,Li Chen,Lei Fan,Xiao-Yan Ma,Shen Zhao,Xiao-Qing Song,Xin Hu,Wentao Yang,Wen-Jun Chai,Xiaomao Guo,Xi-Zi Chen,Yanhui Xu,Xiaoyu Zhu,Jianjun Zou,Zhong-hua Wang,Yi-Zhou Jiang,Zhi Ming Shao +17 more
TL;DR: In this article , the authors investigated patient subpopulations more likely to benefit from immunotherapy and inform more effective combination regimens for TNBC patients, and they conducted exploratory analyses in the FUSCC cohort to characterize a novel patient selection method and actionable targets for triple-negative breast cancer immunotherapy.
Journal ArticleDOI
Identification of the genomic insertion site of Pmel-1 TCR α and β transgenes by next-generation sequencing.
Yun Ji,Natalie Abrams,Wei Zhu,Eddie Salinas,Zhiya Yu,Douglas C. Palmer,Parthav Jailwala,Zulmarie Franco,Rahul Roychoudhuri,Eric A. Stahlberg,Luca Gattinoni,Nicholas P. Restifo +11 more
TL;DR: It is shown that whole genome sequencing can be used to determine the exact pmel-1 genomic integration site, even with relatively ‘shallow’ (8X) coverage, and that next-generation sequencing provides a feasible approach for mapping foreign DNA integration sites, even when information of the original vector sequences is only partially known.
Journal ArticleDOI
Integrated regulation of the cellular metabolism and function of immune cells in adipose tissue.
Yumiko Oishi,Ichiro Manabe +1 more
TL;DR: The current understanding of the specific metabolic signatures adopted by lymphocytes and macrophages to mediate proper effecter function is summarized and findings will be related to the regulation of adipose tissue homeostasis and inflammation.
Journal ArticleDOI
Hexokinase 2 is dispensable for T cell-dependent immunity
Manan M. Mehta,Samuel E. Weinberg,Elizabeth M. Steinert,Krishan D. Chhiba,Carlos A. Martinez,Peng Gao,Harris Perlman,Paul J. Bryce,Nissim Hay,Navdeep S. Chandel +9 more
TL;DR: The finding that T cells are able to withstand the loss of HK2 indicates that HK2 may be a promising candidate for cancer therapy and identifies several other potential metabolic targets in T-ALL leukemia that could spare T cell function.
Journal ArticleDOI
Evolutionary metabolic landscape from preneoplasia to invasive lung adenocarcinoma.
Meng Nie,Ke Yao,Xinsheng Zhu,Na Chen,Nan Xiao,Yi Wang,Bo Peng,LiAng Yao,Peng Li,Peng Li,Peng Zhang,Zeping Hu +11 more
TL;DR: In this article, a large-scale targeted metabolomics on resected lesions and plasma obtained from invasive lung adenocarcinoma (LUAD) and its precursors was performed, revealing that perturbed metabolic pathways emerge early in premalignant lesions.
References
More filters
Journal ArticleDOI
Lineage relationship and protective immunity of memory CD8 T cell subsets.
E. John Wherry,Volker Teichgräber,Todd C. Becker,David Masopust,Susan M. Kaech,Rustom Antia,Ulrich H. von Andrian,Rafi Ahmed +7 more
TL;DR: It is proposed that TCM and TEM do not necessarily represent distinct subsets, but are part of a continuum in a linear naive → effector → TEM → TCM differentiation pathway.
Journal ArticleDOI
Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T Cell Transfer Immunotherapy
Steven A. Rosenberg,James Chih-Hsin Yang,Richard M. Sherry,Udai S. Kammula,Michael S. Hughes,Giao Q. Phan,Deborah Citrin,Nicholas P. Restifo,Paul F. Robbins,John R. Wunderlich,Kathleen E. Morton,Carolyn M. Laurencot,Seth M. Steinberg,Donald E. White,Mark E. Dudley +14 more
TL;DR: Cell transfer therapy with autologous TILs can mediate durable complete responses in patients with metastatic melanoma and has similar efficacy irrespective of prior treatment.
Journal ArticleDOI
Posttranscriptional Control of T Cell Effector Function by Aerobic Glycolysis
Chih-Hao Chang,Jonathan D. Curtis,Leonard B. Maggi,Brandon Faubert,Alejandro V. Villarino,David O’Sullivan,Stanley Ching-Cheng Huang,Gerritje J.W. van der Windt,Julianna Blagih,Jing Qiu,Jason D. Weber,Edward J. Pearce,Russell G. Jones,Erika L. Pearce +13 more
TL;DR: It is shown here that aerobic glycolysis is specifically required for effector function in T cells but that this pathway is not necessary for proliferation or survival.
Journal ArticleDOI
The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation
Ruoning Wang,Christopher P. Dillon,Lewis Zhichang Shi,Sandra Milasta,Robert Carter,David Finkelstein,Laura L. McCormick,Patrick Fitzgerald,Hongbo Chi,Joshua Munger,Douglas R. Green +10 more
TL;DR: Metabolic tracer analysis revealed a Myc-dependent metabolic pathway linking glutaminolysis to the biosynthesis of polyamines, which may represent a general mechanism for metabolic reprogramming under patho-physiological conditions.
Journal ArticleDOI
Cutting Edge: Distinct Glycolytic and Lipid Oxidative Metabolic Programs Are Essential for Effector and Regulatory CD4+ T Cell Subsets
Ryan D. Michalek,Valerie A. Gerriets,Sarah R. Jacobs,Andrew N. Macintyre,Nancie J. MacIver,Emily F. Mason,Sarah A. Sullivan,Amanda G. Nichols,Jeffrey C. Rathmell +8 more
TL;DR: Teff and Treg were selectively increased in Glut1 transgenic mice and reliant on glucose metabolism, whereas Treg had activated AMP-activated protein kinase and were dependent on lipid oxidation.